RECORD // Company

Sana Biotechnology, Inc.

Built 2026-11-22T03:06:31Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (7)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Sana Biotechnology, Inc. · Ct business · same registered legal name as 'Sana Biotechnology, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Sana Biotechnology · Ctgov · exact name match to 'Sana Biotechnology, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • SANA BIOTECHNOLOGY, INC. · Epa echo · same registered legal name as 'Sana Biotechnology, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • SANA BIOTECHNOLOGY INC · Epa rcra · same registered legal name as 'Sana Biotechnology, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • SANA BIOTECHNOLOGY INC · Lic sw · same registered legal name as 'Sana Biotechnology, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • SANA BIOTECHNOLOGY, INC. · Ny corps · same registered legal name as 'Sana Biotechnology, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • SANA BIOTECHNOLOGY INC · Seattle business licence certificates · same registered legal name as 'Sana Biotechnology, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

2 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001193125-26-449836

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$20,401,0003 months ended 2026-09-3010-Q2026-11-050001193125-26-4498362026-11-22 03:06 UTCReport an error
Cash and cash equivalents$41,104,000at 2026-09-3010-Q2026-11-050001193125-26-4498362026-11-22 03:06 UTCReport an error

Not in this report's XBRL: Revenue, Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001770121
Ticker
SANA
EIN
831381173
CUSIP
799566104
Record ID
sx:sec:0001770121

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

39 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-05SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-05SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
State of incorporationDE2026-11-05SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
Fiscal year end (MMDD)12312026-11-05SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
Business address188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA2026-11-05SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
ExchangesNasdaq2026-11-05SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-244,166,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 03:06 UTCReport an error
Total assets (at 2025-12-31)$416,890,0002025-12-3110-K, XBRL Assets2026-11-22 03:06 UTCReport an error
Stockholders' equity (at 2025-12-31)$160,884,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 03:06 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$71,870,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:06 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-143,828,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:06 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$938,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 03:06 UTCReport an error
Operating lease liabilities (at 2025-12-31)$78,862,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 03:06 UTCReport an error
Form D total offering amount (D filed 2020-06-26)$821,097,5212020-06-26D2026-11-22 03:06 UTCReport an error
Form D total amount sold (D filed 2020-06-26)$821,097,5212020-06-26D2026-11-22 03:06 UTCReport an error
Form D industry groupBiotechnology2020-06-26D2026-11-22 03:06 UTCReport an error
Form D revenue rangeDecline to Disclose2020-06-26D2026-11-22 03:06 UTCReport an error
Form D date of first sale2019-02-132020-06-26D2026-11-22 03:06 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-05)On November 5, 2026, Sana Biotechnology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1. The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth…2026-11-05SEC EDGAR 8-K 0001193125-26-449791 (text as filed, excerpt)2026-11-22 03:06 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-10)On August 10, 2026, Sana Biotechnology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1. The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by…2026-08-10SEC EDGAR 8-K 0001193125-26-342371 (text as filed, excerpt)2026-11-22 03:06 UTCReport an error
Employer name (as filed)Sana Biotechnology, Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 03:06 UTCReport an error
Certified LCAs42026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 03:06 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 03:06 UTCReport an error
Total worker positions on certified LCAs42026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 03:06 UTCReport an error
Top job titles (title, LCA count)Principal Scientist (1); Principal Research Associate (1); Senior Scientist (1); Scientist (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 03:06 UTCReport an error
Wage offered, annualized (n, min, median, max)median $166,635 (range $113,464-$190,000, 4 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 03:06 UTCReport an error
Worksite statesCA; MA2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 03:06 UTCReport an error
Plan (pension, plan no. 001)SANA BIOTECHNOLOGY, INC. 401(K) PLAN: 501 participants, assets $43,290,1342025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 03:06 UTCReport an error
Plan (welfare, plan no. 501)SANA BIOTECHNOLOGY, INC. EMPLOYEE BENEFITS PLAN: 145 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 03:06 UTCReport an error
Largest institutional holder #1 (13F as filed): FMR LLC$130,629,0072026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #2 (13F as filed): Flagship Pioneering, LLC$87,256,4772026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #3 (13F as filed): RA CAPITAL MANAGEMENT, L.P.$65,437,5002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #4 (13F as filed): BlackRock, Inc.$58,196,3542026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #5 (13F as filed): STATE STREET CORP$39,098,9382026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #6 (13F as filed): CANADA PENSION PLAN INVESTMENT BOARD$35,662,2162026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #7 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$29,230,2192026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #8 (13F as filed): BANK OF AMERICA CORP /DE/$20,062,1052026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #9 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$16,329,0822026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error
Largest institutional holder #10 (13F as filed): Marex Group Ltd$13,921,9592026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:06 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.